Magnesium Sulfate Versus Nifedipine for the Acute Tocolysis of Preterm Labor: A Prospective, Randomized Trial
Information source: Stanford University
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Obstetric Labor, Premature
Intervention: stopping preterm labor (Drug); Nifedipine or Magnesium Sulfate (Drug)
Phase: N/A
Status: Completed
Sponsored by: Stanford University Official(s) and/or principal investigator(s):
Yasser Yehia El-Sayed, Principal Investigator, Affiliation: Stanford University
Summary
To compare intravenous magnesium sulfate to oral nifedipine for acute tocolysis of preterm
labor
Clinical Details
Study design: Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Primary outcome: No delivery in 48 hours and uterine quiescence
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Female.
Criteria:
Inclusion Criteria::- Uterine contractions and cervical change or ruptured membranes in a
preterm gestation Exclusion Criteria:- placental abruption, fetal distress, placenta
previa, maternal medical contraindication to tocolysis
Locations and Contacts
Stanford University School of Medicine, Stanford, California 94305, United States
Additional Information
Last updated: May 9, 2008
|
